title: Clinical significance of acute neurohormonal response after levosimendan treatment.
authors.forename: George
authors.initials: G
authors.lastname: Giannakoulas
authors.forename: George
authors.initials: G
authors.lastname: Giannoglou
authors.forename: Vasilis
authors.initials: V
authors.lastname: Vassilikos
authors.forename: Kostantina
authors.initials: K
authors.lastname: Martiadou
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Kalpidis
authors.forename: George
authors.initials: G
authors.lastname: Parharidis
authors.forename: George
authors.initials: G
authors.lastname: Louridas
mesh_terms: D000368:Aged; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D008297:Male; D020097:Natriuretic Peptide, Brain / Q000097:blood / Q000378:metabolism*; D011724:Pyridazines / Q000627:therapeutic use*; D000077464:Simendan; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D020097:Natriuretic Peptide, Brain; D000077464:Simendan